Style | Citing Format |
---|---|
MLA | Ziaei E, et al.. "Pulmonary Delivery of Docetaxel and Celecoxib by Plga Porous Microparticles for Their Synergistic Effects Against Lung Cancer." Anti-Cancer Agents in Medicinal Chemistry, vol. 22, no. 5, 2022, pp. 951-967. |
APA | Ziaei E, Emami J, Rezazadeh M, Kazemi M (2022). Pulmonary Delivery of Docetaxel and Celecoxib by Plga Porous Microparticles for Their Synergistic Effects Against Lung Cancer. Anti-Cancer Agents in Medicinal Chemistry, 22(5), 951-967. |
Chicago | Ziaei E, Emami J, Rezazadeh M, Kazemi M. "Pulmonary Delivery of Docetaxel and Celecoxib by Plga Porous Microparticles for Their Synergistic Effects Against Lung Cancer." Anti-Cancer Agents in Medicinal Chemistry 22, no. 5 (2022): 951-967. |
Harvard | Ziaei E et al. (2022) 'Pulmonary Delivery of Docetaxel and Celecoxib by Plga Porous Microparticles for Their Synergistic Effects Against Lung Cancer', Anti-Cancer Agents in Medicinal Chemistry, 22(5), pp. 951-967. |
Vancouver | Ziaei E, Emami J, Rezazadeh M, Kazemi M. Pulmonary Delivery of Docetaxel and Celecoxib by Plga Porous Microparticles for Their Synergistic Effects Against Lung Cancer. Anti-Cancer Agents in Medicinal Chemistry. 2022;22(5):951-967. |
BibTex | @article{ author = {Ziaei E and Emami J and Rezazadeh M and Kazemi M}, title = {Pulmonary Delivery of Docetaxel and Celecoxib by Plga Porous Microparticles for Their Synergistic Effects Against Lung Cancer}, journal = {Anti-Cancer Agents in Medicinal Chemistry}, volume = {22}, number = {5}, pages = {951-967}, year = {2022} } |
RIS | TY - JOUR AU - Ziaei E AU - Emami J AU - Rezazadeh M AU - Kazemi M TI - Pulmonary Delivery of Docetaxel and Celecoxib by Plga Porous Microparticles for Their Synergistic Effects Against Lung Cancer JO - Anti-Cancer Agents in Medicinal Chemistry VL - 22 IS - 5 SP - 951 EP - 967 PY - 2022 ER - |